Medication-Associated Osteonecrosis: Exploring the Efficacy of Sonodynamic Therapy in a Series of Cases

Ms. Larissa Agatti,Dr. Paulo Moraes,Dr. Aguinaldo Garcez,Ms. Luiza Hellmeister,Dr. Daniela Prata Tacchelli,Dr. Marcelo Sperandio,Dr. Victor Montalli
DOI: https://doi.org/10.1016/j.oooo.2024.04.032
2024-07-14
Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology
Abstract:This study presents a series of six cases involving patients who underwent previous cancer treatments and utilized bisphosphonates, monoclonal antibodies, and high-dose corticosteroids, subsequently experiencing osteonecrosis in the oral cavity. The associated challenges included pain, recurrent infections, diminished quality of life—especially in terms of food intake—and social discomfort due to characteristic lesion odor. Medication-associated osteonecrosis (OAM) is identified as an injury leading to the temporary or permanent loss of blood supply to bones, with diverse causal factors.
dentistry, oral surgery & medicine
What problem does this paper attempt to address?